NASDAQ:NVAX

Novavax Stock Predictions

etoro logo Buy NVAX
*Your capital is at risk
$10.20
-0.0100 (-0.0979%)
At Close: Jun 03, 2026
Currently predicting for Thu, 4 Jun 2026

NVAX Prediction Chart

NVAX Predictions History

Latest community submissions for NVAX.
Predictor Target Session Target Price Result Direction Accuracy Score
JS JS Pro
Jul 8, 2020 $94.27 -4.10% $98.30 X 95.90% 1
Jose Fernandez Rana Jose Fernandez Rana @JoseFernandezRana.167100
Jul 6, 2020 Bearish $79.44 X 1
JS JS Pro
Jun 25, 2020 $81.52 -2.42% $83.54 X 97.58% 1
JS JS Pro
May 26, 2020 $40.19 -16.57% $48.17 X 83.43% 0
2poJeff 2poJeff Pro
May 26, 2020 $47.15 -2.12% $48.17 X 97.88% 1
May 18, 2020 $44.51 -21.86% $56.96 X 78.14% 1
JS JS Pro
May 18, 2020 $46.78 -17.87% $56.96 X 82.13% 1
2poJeff 2poJeff Pro
May 18, 2020 $43.61 -23.44% $56.96 X 76.56% 1
JS JS Pro
May 14, 2020 $34.38 -10.23% $38.30 X 89.77% 1
Zhiqiao Huang Zhiqiao Huang @ZhiqiaoHuang.159234
May 14, 2020 Bullish $38.30 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for NVAX with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT NOVAVAX INC
Novavax
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; NanoFlu, a nanoparticle seasonal quadrivalent influenza vaccine candidate that is in Phase 3 clinical tria...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE